SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?


To: SDR-SI who wrote (743)9/22/1998 7:07:00 PM
From: Candle stick  Respond to of 1686
 
Biogen, Inc downgraded by Hambrecht & Quist

Tuesday September 22, 2:42 pm Eastern Time

RESEARCH ALERT - Biogen cut to buy

LOS ANGELES, Sept 22 (Reuters) - Hambrecht & Quist on Tuesday cut its rating on Biogen Inc. to buy from strong buy.

--said the cut was due to recent price appreciation.

--said he company remains H&Q's favorite large-cap biotech company but said recent price appreciation deserved a less
aggressive rating.

--shares of Biogen were 3/8 higher at 67 in afternoon trading on Nasdaq.

More Quotes and News:
Biogen Inc (Nasdaq:BGEN - news)
Related News Categories: health, US Market News

biz.yahoo.com